Biovenic's Tech Goes Veterinary

For the past two decades, CAR therapies have revolutionized human oncology. Meanwhile, similar strategies in veterinary medicine have taken hold. Biovenic is changing that narrative by providing tailored solutions—veterinary CAR-T therapydevelopment—to tackle challenges in developing immune cell therapies for veterinary use.